Sorghum is an important source of food, feed and raw material for brewing, and is expected to be a promising bioenergy crop. Sorghum is well known for its strong resistance to abiotic stress and wide adaptability, and...Sorghum is an important source of food, feed and raw material for brewing, and is expected to be a promising bioenergy crop. Sorghum is well known for its strong resistance to abiotic stress and wide adaptability, and salt tolerance is one of its main characteristics. Increasing sorghum planting acreage on saline-alkalien land is one way to effectively use this kind of marginal soil. In this paper, domestic and overseas research on plant tolerance to soil salinity and alkalinity in sorghum, including salt-tolerant genetics and breeding, physiology, cultivation, and identification of tolerant germplasms, are reviewed. Suggestions for further studies on salinity and alkalinity tolerance in sorghum are given, and the prospects for sorghum production in saline-alkalien land are discussed.展开更多
The majority of individuals exposed to hepatitis C virus(HCV) establish a persistent infection,which is a leading cause of chronic liver disease,cirrhosis and hepatocellular carcinoma.Major progress has been made duri...The majority of individuals exposed to hepatitis C virus(HCV) establish a persistent infection,which is a leading cause of chronic liver disease,cirrhosis and hepatocellular carcinoma.Major progress has been made during the past twenty-five years in understanding the HCV life cycle and immune responses against HCV infection.Increasing evidence indicates that host genetic factors can significantly influence the outcome of HCV infection and the response to interferon alpha-based antiviral therapy.The arrival of highly effective and convenient treatment regimens for patients chronically infected with HCV has improved prospects for the eradication of HCV worldwide.Clinical trials are evaluating the best anti-viral drug combination,treatment doses and duration.The new treatments are better-tolerated and have shown success rates of more than 95%.However,the recent breakthrough in HCV treatment raises new questions and challenges,including the identification of HCVinfected patients and to link them to appropriate health care,the high pricing of HCV drugs,the emergence of drug resistance or naturally occurring polymorphism in HCV sequences which can compromise HCV treatment response.Finally,we still do not have a vaccine against HCV.In this concise review,we will highlight the progress made in understanding HCV infection and therapy.We will focus on the most significant unsolved problems and the key future challenges in the management of HCV infection.展开更多
基金supported by the earmarked fund for China Agriculture Research System(CARS-06)
文摘Sorghum is an important source of food, feed and raw material for brewing, and is expected to be a promising bioenergy crop. Sorghum is well known for its strong resistance to abiotic stress and wide adaptability, and salt tolerance is one of its main characteristics. Increasing sorghum planting acreage on saline-alkalien land is one way to effectively use this kind of marginal soil. In this paper, domestic and overseas research on plant tolerance to soil salinity and alkalinity in sorghum, including salt-tolerant genetics and breeding, physiology, cultivation, and identification of tolerant germplasms, are reviewed. Suggestions for further studies on salinity and alkalinity tolerance in sorghum are given, and the prospects for sorghum production in saline-alkalien land are discussed.
文摘The majority of individuals exposed to hepatitis C virus(HCV) establish a persistent infection,which is a leading cause of chronic liver disease,cirrhosis and hepatocellular carcinoma.Major progress has been made during the past twenty-five years in understanding the HCV life cycle and immune responses against HCV infection.Increasing evidence indicates that host genetic factors can significantly influence the outcome of HCV infection and the response to interferon alpha-based antiviral therapy.The arrival of highly effective and convenient treatment regimens for patients chronically infected with HCV has improved prospects for the eradication of HCV worldwide.Clinical trials are evaluating the best anti-viral drug combination,treatment doses and duration.The new treatments are better-tolerated and have shown success rates of more than 95%.However,the recent breakthrough in HCV treatment raises new questions and challenges,including the identification of HCVinfected patients and to link them to appropriate health care,the high pricing of HCV drugs,the emergence of drug resistance or naturally occurring polymorphism in HCV sequences which can compromise HCV treatment response.Finally,we still do not have a vaccine against HCV.In this concise review,we will highlight the progress made in understanding HCV infection and therapy.We will focus on the most significant unsolved problems and the key future challenges in the management of HCV infection.
